IBRX company logo

ImmunityBio, Inc. Common Stock (IBRX) Stock

NASDAQ · IBRX
Trade IBRX

Key stats

Market cap
$8.81B
Price / Earnings ratio
-9.2x
EPS (TTM)
-$1.31
Volume
Loading
52-week high
$12.43
52-week low
$1.95

Source: third-party data provider, as of October 24, 2026

Compare with IBRX

Recent news

Stocktwits

ImmunityBio Locks Anktiva Trial Database, Eyes November Results As FDA Filing Nears

IBRXOctober 21, 2026
Business Wire

ImmunityBio Announces Database Lock for Registrational Trial of Locally Delivered, Chemotherapy-Free ANKTIVA® Plus BCG in BCG-Naïve Non-Muscle Invasive Bladder Cancer

NeutralIBRXOctober 21, 2026
Business Wire

ImmunityBio Reports Phase 3 Data Showing 84% Cystectomy Avoidance at Three Years and Complete Responses Beyond 53 Months with ANKTIVA® Plus BCG in BCG-Unresponsive NMIBC With CIS, With or Without Papillary Tumors

NeutralIBRXOctober 16, 2026
Zacks Investment Research

FDA Expands ImmunityBio's Anktiva Label in Bladder Cancer

PositiveIBRXOctober 15, 2026

News tone: automated (AI) classification of the article's content, not a price prediction.

Technical indicators

RSI 14
41.57
MACD 12/26/9
0.03
EMA 9 of MACD
0.27
MACD histogram
-0.23
SMA 50
$8.63
Price below SMA 50
EMA 50
$8.77
Price below EMA 50
SMA 200
$7.73
Price above SMA 200
EMA 200
$7.13
Price above EMA 200

Calculated by Gotrade from daily closing prices, as of October 22, 2026. Technical data, not a recommendation.

Analyst ratings

Analyst consensus: Buy

Based on 2 analyst ratings

Strong Sell0
Sell0
Hold0
Buy2
Strong Buy0

Third-party analyst opinion, not a recommendation from Gotrade.

Financials

Performance

Revenue
Net income
Net margin %
2025
136M90M45M0

Debt & Balance Sheet

Total assets
Total liabilities
2025
1B793M397M0

Revenue to Profit

2025
$113.3M
Revenue
$0.0
Cost of revenue
$112.5M
Gross profit
$0.0
Operating expenses
$-351.4M
Net income

Earnings

No data available

Source: third-party data provider

Stocks in the same sector

INCY
Incyte
NKTR
Nektar Therapeutics
REGN
Regeneron
VRTX
Vertex Pharmaceuticals
ABEO
Abeona Therapeutics Inc.
ACIU
AC IMMUNE SA
ACAD
ACADIA Pharma
ADPT
Adaptive Biotech

FAQ

Buying ImmunityBio, Inc. Common Stock (IBRX) stock is now easy and instant through the Gotrade app.
  1. Download the Gotrade app from the App Store or Google Play.
  2. Create an account and complete KYC.
  3. Make a deposit.
  4. Search for the code "IBRX", then tap "Trade".
  5. Tap the "Buy" button.
  6. Enter the amount you want to buy. You have two options:
    1. Buy IBRX by number of shares.
    2. Buy fractional shares in dollars, starting from $1.
  7. Swipe up to confirm your order, and you're done!
On Gotrade, you don't have to buy a full lot. With fractional shares, you can start investing in ImmunityBio, Inc. Common Stock from just $1. A small budget shouldn't stop you from building a US stock portfolio.
At the moment, ImmunityBio, Inc. Common Stock (IBRX) does not pay dividends because it focuses on reinvesting profits for company growth (a growth stock). However, you can still potentially earn profit from share price increases (capital gains). Track IBRX's performance via the price chart in the Gotrade app.
Gotrade is the trading name of Gotrade Securities Inc., which is registered with and supervised by the Labuan Financial Services Authority (LFSA).
You can place orders 24/7. Transactions will be executed when the US market (NYSE/NASDAQ) is open, from 9:30 PM to 4:00 AM WIB, or 8:30 PM to 3:00 AM WIB during Daylight Saving Time. Gotrade also provides access to pre-market and after-hours trading, so you have more flexibility and aren't limited to regular working hours.
Market hours may change due to daylight saving time and holidays. In Gotrade, you can see the market status (open/closed) directly in the app.
There's no single perfect answer, but common approaches include:
  • Compare valuation (e.g., P/E, P/S) against historical averages or competitors.
  • Review revenue and earnings growth.
  • Check margins and cash flow.
  • Evaluate business outlook and the company's position within its industry.
You can combine fundamental analysis with an investing strategy that matches your risk profile. All of the information above can be viewed directly in the Gotrade app.
Mockup Two Phones

Trade Faster. Easier. Smarter.

#ReadyGoTrade

Gotrade Green Logo Top Left

Welcome Reward up to $1,888

Create an account and trade US stocks on Gotrade

Download app

*Terms & conditions apply